Literature DB >> 23450586

Red flags to screen for malignancy in patients with low-back pain.

Nicholas Henschke1, Christopher G Maher, Raymond W J G Ostelo, Henrica C W de Vet, Petra Macaskill, Les Irwig.   

Abstract

BACKGROUND: The identification of serious pathologies, such as spinal malignancy, is one of the primary purposes of the clinical assessment of patients with low-back pain (LBP). Clinical guidelines recommend awareness of "red flag" features from the patient's clinical history and physical examination to achieve this. However, there are limited empirical data on the diagnostic accuracy of these features and there remains very little information on how best to use them in clinical practice.
OBJECTIVES: To assess the diagnostic performance of clinical characteristics identified by taking a clinical history and conducting a physical examination ("red flags") to screen for spinal malignancy in patients presenting with LBP. SEARCH
METHODS: We searched electronic databases for primary studies (MEDLINE, EMBASE, and CINAHL) and systematic reviews (PubMed and Medion) from the earliest date until 1 April 2012. Forward and backward citation searching of eligible articles was also performed. SELECTION CRITERIA: We considered studies if they compared the results of history taking and physical examination on patients with LBP with those of diagnostic imaging (magnetic resonance imaging, computed tomography, myelography). DATA COLLECTION AND ANALYSIS: Two review authors independently assessed the quality of each included study with the QUality Assessment of Diagnostic Accuracy Studies (QUADAS) tool and extracted details on patient characteristics, study design, index tests, and reference standard. Diagnostic accuracy data were presented as sensitivities and specificities with 95% confidence intervals for all index tests. MAIN
RESULTS: We included eight cohort studies of which six were performed in primary care (total number of patients; n = 6622), one study was from an accident and emergency setting (n = 482), and one study was from a secondary care setting (n = 257). In the six primary care studies, the prevalence of spinal malignancy ranged from 0% to 0.66%. Overall, data from 20 index tests were extracted and presented, however only seven of these were evaluated by more than one study. Because of the limited number of studies and clinical heterogeneity, statistical pooling of diagnostic accuracy data was not performed.There was some evidence from individual studies that having a previous history of cancer meaningfully increases the probability of malignancy. Most "red flags" such as insidious onset, age > 50, and failure to improve after one month have high false positive rates.All of the tests were evaluated in isolation and no study presented data on a combination of positive tests to identify spinal malignancy. AUTHORS'
CONCLUSIONS: For most "red flags," there is insufficient evidence to provide recommendations regarding their diagnostic accuracy or usefulness for detecting spinal malignancy. The available evidence indicates that in patients with LBP, an indication of spinal malignancy should not be based on the results of one single "red flag" question. Further research to evaluate the performance of different combinations of tests is recommended.

Entities:  

Mesh:

Year:  2013        PMID: 23450586     DOI: 10.1002/14651858.CD008686.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  21 in total

Review 1.  Diagnosis and management of low-back pain in primary care.

Authors:  Adrian Traeger; Rachelle Buchbinder; Ian Harris; Chris Maher
Journal:  CMAJ       Date:  2017-11-13       Impact factor: 8.262

Review 2.  Defining and measuring imaging appropriateness in low back pain studies: a scoping review.

Authors:  Mark Yates; Crystian B Oliveira; James B Galloway; Chris G Maher
Journal:  Eur Spine J       Date:  2020-01-14       Impact factor: 3.134

Review 3.  [Treatment strategies for pathological fractures of the spine].

Authors:  M Pishnamaz; V Quack; C Herren; F Hildebrand; P Kobbe
Journal:  Unfallchirurg       Date:  2021-08-03       Impact factor: 1.000

4.  Evidence base and future research directions in the management of low back pain.

Authors:  Allan Abbott
Journal:  World J Orthop       Date:  2016-03-18

5.  Multi-functionality of computer-aided quantitative vertebral fracture morphometry analyses.

Authors:  Ling Oei; Felisia Ly; Salih El Saddy; Ater A Makurthou; Albert Hofman; Frank J A van Rooij; André G Uitterlinden; M Carola Zillikens; Fernando Rivadeneira; Edwin H G Oei
Journal:  Quant Imaging Med Surg       Date:  2013-10

6.  Headache neuroimaging: A survey of current practice, barriers, and facilitators to optimal use.

Authors:  Evan L Reynolds; James F Burke; Lacey Evans; Faiz I Syed; Eric Liao; Remy Lobo; Wade Cooper; Larry Charleston; Brian C Callaghan
Journal:  Headache       Date:  2022-01       Impact factor: 5.311

7.  The etiologies of low back pain in patients with lumbar disk herniation.

Authors:  Fariborz Samini; Mohammad Gharedaghi; Mahdi Khajavi; Mohammad Samini
Journal:  Iran Red Crescent Med J       Date:  2014-10-05       Impact factor: 0.611

Review 8.  Red flags to screen for malignancy and fracture in patients with low back pain: systematic review.

Authors:  Aron Downie; Christopher M Williams; Nicholas Henschke; Mark J Hancock; Raymond W J G Ostelo; Henrica C W de Vet; Petra Macaskill; Les Irwig; Maurits W van Tulder; Bart W Koes; Christopher G Maher
Journal:  BMJ       Date:  2013-12-11

9.  The screening process of a patient with low back pain and suspected thoracic myelopathy: a case report.

Authors:  Guillaume Christe; Toby Hall
Journal:  J Man Manip Ther       Date:  2017-01-23

10.  Analysis of non-traumatic truncal back pain in patients who visited an emergency room.

Authors:  Masataka Nagayama; Youichi Yanagawa; Koichiro Aihara; Shin Watanabe; Masaaki Takemoto; Tomoko Nakazato; Takashi Hashimoto; Toshio Takayama; Yuuji Takazawa; Toshiaki Iba; Kazuo Kaneko; Hiroshi Tanaka
Journal:  Acute Med Surg       Date:  2014-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.